180 Wealth Advisors’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,460
| Closed | -$215K | – | 508 |
|
|
2026
Q1 | $215K | Sell |
4,460
-709
| -14% | -$33.1K | 0.02% | 437 |
|
|
2025
Q4 | $250K | Sell |
5,169
-1,020
| -16% | -$50.6K | 0.03% | 397 |
|
|
2025
Q3 | $292K | Sell |
6,189
-12
| -0.2% | -$579 | 0.04% | 368 |
|
|
2025
Q2 | $300K | Sell |
6,201
-70
| -1% | -$3.58K | 0.04% | 338 |
|
|
2025
Q1 | $348K | Sell |
6,271
-806
| -11% | -$43.6K | 0.06% | 290 |
|
|
2024
Q4 | $341K | Sell |
7,077
-175
| -2% | -$8.9K | 0.05% | 297 |
|
|
2024
Q3 | $418K | Buy |
7,252
+44
| +0.6% | +$2.38K | 0.07% | 260 |
|
|
2024
Q2 | $369K | Buy |
7,208
+414
| +6% | +$20K | 0.06% | 273 |
|
|
2024
Q1 | $330K | Buy |
6,794
+215
| +3% | +$10.5K | 0.06% | 275 |
|
|
2023
Q4 | $329K | Sell |
6,579
-274
| -4% | -$13.4K | 0.07% | 261 |
|
|
2023
Q3 | $368K | Buy |
6,853
+393
| +6% | +$21K | 0.08% | 234 |
|
|
2023
Q2 | $346K | Sell |
6,460
-361
| -5% | -$19.4K | 0.08% | 233 |
|
|
2023
Q1 | $371K | Buy |
6,821
+67
| +1% | +$3.26K | 0.09% | 226 |
|
|
2022
Q4 | $330K | Sell |
6,754
-2,572
| -28% | -$113K | 0.08% | 245 |
|
|
2022
Q3 | $355K | Buy |
9,326
+2,432
| +35% | +$108K | 0.1% | 207 |
|
|
2022
Q2 | $352K | Buy |
6,894
+410
| +6% | +$21.8K | 0.09% | 215 |
|
|
2022
Q1 | $358K | Buy |
6,484
+307
| +5% | +$15.9K | 0.08% | 243 |
|
|
2021
Q4 | $317K | Buy |
6,177
+146
| +2% | +$7.22K | 0.07% | 267 |
|
|
2021
Q3 | $295K | Sell |
6,031
-9
| -0.1% | -$458 | 0.07% | 286 |
|
|
2021
Q2 | $307K | Buy |
6,040
+9
| +0.1% | +$470 | 0.07% | 273 |
|
|
2021
Q1 | $325K | Sell |
6,031
-30
| -0.5% | -$1.44K | 0.08% | 233 |
|
|
2020
Q4 | $306K | Buy |
6,061
+927
| +18% | +$45.7K | 0.09% | 219 |
|
|
2020
Q3 | $256K | Buy |
5,134
+118
| +2% | +$6.08K | 0.1% | 203 |
|
|
2020
Q2 | $267K | Sell |
5,016
-186
| -4% | -$9.04K | 0.11% | 193 |
|
|
2020
Q1 | $226K | Sell |
5,202
-447
| -8% | -$21.4K | 0.12% | 187 |
|
|
2019
Q4 | $290K | Sell |
5,649
-349
| -6% | -$16.3K | 0.12% | 205 |
|
|
2019
Q3 | $270K | Sell |
5,998
-276
| -4% | -$11.9K | 0.12% | 203 |
|
|
2019
Q2 | $263K | Sell |
6,274
-2,815
| -31% | -$120K | 0.12% | 202 |
|
|
2019
Q1 | $374K | Sell |
9,089
-1,286
| -12% | -$55.1K | 0.17% | 150 |
|
|
2018
Q4 | $463K | Hold |
10,375
| – | – | 0.22% | 140 |
|
|
2018
Q3 | $463K | Sell |
10,375
-229
| -2% | -$9.78K | 0.21% | 141 |
|
|
2018
Q2 | $424K | Buy |
10,604
+1,168
| +12% | +$46K | 0.21% | 138 |
|
|
2018
Q1 | $371K | Sell |
9,436
-1,698
| -15% | -$70.7K | 0.19% | 141 |
|
|
2017
Q4 | $479K | Buy |
+11,134
| New | +$513K | 0.24% | 116 |
|
Other funds holding SNY
DC
QCM
MFG
TNB
SIS
FBT
FB
CAMG
180 Wealth Advisors's SNY Position: Q2 2026 in Review
180 Wealth Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,460 shares — an estimated $215K sold.
180 Wealth Advisors first reported a position in SNY in Q4 2017 and held it in 34 quarters. The position peaked at $479K in Q4 2017. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- 180 Wealth Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
- 180 Wealth Advisors sold 4,460 Sanofi shares in Q2 2026, an estimated $215K.
- 180 Wealth Advisors first reported a position in Sanofi in Q4 2017 and held it in 34 quarters.
- 180 Wealth Advisors's Sanofi position peaked at $479K in Q4 2017.
- 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.